AQR Capital Management’s Relay Therapeutics RLAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.8M Buy
1,290,032
+126,908
+11% +$1.14M 0.01% 1228
2025
Q4
$9.84M Sell
1,163,124
-137,912
-11% -$984K 0.01% 1225
2025
Q3
$6.79M Buy
1,301,036
+217,571
+20% +$830K ﹤0.01% 1276
2025
Q2
$3.75M Buy
1,083,465
+718,519
+197% +$2.14M ﹤0.01% 1445
2025
Q1
$956K Buy
364,946
+38,812
+12% +$152K ﹤0.01% 2043
2024
Q4
$1.34M Buy
326,134
+302,742
+1,294% +$1.65M ﹤0.01% 1731
2024
Q3
$166K Sell
23,392
-43,851
-65% -$328K ﹤0.01% 2601
2024
Q2
$438K Buy
67,243
+52,693
+362% +$360K ﹤0.01% 2104
2024
Q1
$121K Buy
14,550
+3,049
+27% +$29.7K ﹤0.01% 2320
2023
Q4
$127K Buy
+11,501
New +$97K ﹤0.01% 2265

Other funds holding RLAY